← Back to front page
United States · Platforms & data · MarketBeat

Acrivon Therapeutics (NASDAQ:ACRV) Stock Keeps "Market Outperform" Rating at Citizens Jmp

Published by MarketBeat · United States 32 min ago
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Citizens Jmp reissued a "market outperform" rating on shares of Acrivon Therapeutics in a report on Tuesday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading